SCHEMBL6977873

SCHEMBL6977873

Bc1cccc(C(C)(C)CN)c1

nearest known ligand 0.57

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 2/20 0.57
PRKCQ Q04759 1/20 0.40
HTR2A P28223 2/20 0.33
HTR2C P28335 2/20 0.33
HTR2B P41595 2/20 0.33
SLC6A4 P31645 1/20 0.33
PNMT P11086 1/20 0.33
TSHR P16473 1/20 0.32
MAPK1 P28482 1/20 0.32
KIF11 P52732 3/20 0.31
CYP2C19 P33261 2/20 0.31
CYP3A4 P08684 1/20 0.31
CYP2D6 P10635 1/20 0.31
CYP2C9 P11712 1/20 0.31
KCNH2 Q12809 1/20 0.31
IDO1 P14902 1/20 0.31
ESR1 P03372 1/20 0.31
ESR2 Q92731 1/20 0.31
CYP1A2 P05177 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2593641 0.85 TAAR1 (0.70) TAAR1PRKCQHTR2AHTR2CHTR2B
SCHEMBL8227760 0.80 TAAR1 (0.57) TAAR1PRKCQHTR2AHTR2CHTR2B
SCHEMBL22299378 0.79 TAAR1 (0.61) TAAR1PRKCQKIF11ESR1ESR2
Hydrochloric Acid SCHEMBL3911403 0.78 TAAR1 (0.55) TAAR1HTR2AHTR2CHTR2BSLC6A4
SCHEMBL13385660 0.76 HDAC8 (0.47) TSHRKIF11CYP2C19CYP3A4CYP2C9
SCHEMBL14991287 0.76 TAAR1 (0.57) TAAR1PRKCQHTR2AHTR2CHTR2B
SCHEMBL3978037 0.76 TAAR1 (0.57) TAAR1PRKCQHTR2AHTR2CHTR2B
SCHEMBL21277730 0.76 TAAR1 (0.57) TAAR1PRKCQHTR2AHTR2CHTR2B
SCHEMBL2227553 0.76 TAAR1 (0.57) TAAR1PRKCQHTR2AHTR2CHTR2B
Hydrochloric Acid SCHEMBL16007841 0.76 TAAR1 (0.57) TAAR1PRKCQHTR2AHTR2CHTR2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011088181-A9 COMPOUNDS AND METHODS TEMPERO PHARMACEUTICALS, INC. (US) 2013-01-31 WO disclosed
WO-2011088181-A1 COMPOUNDS AND METHODS TEMPERO PHARMACEUTICALS, INC. (US) 2011-07-21 WO disclosed